State
73,738 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.
Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.
Which agencies issued them
These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,738 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Anderson Compounding Pharmacy is recalling Heparin and Marcaine syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Vancomycin 125 mg/3mL Inhalation vials nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling HCG 23 Day Injection Extra Strength vials nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Papaverine 30 mg/mL Injection vials nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Polyhexamethylene Biguanide 0.02% Ophthalmic Drops due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Streptomycin 24 mg/Dexamethasone 10 mg/mL Otic Injection due to a lack of sterility assurance.
Gyrus ACMI, Inc. is recalling Diego Elite Turbinate Blades because they may allow unintended RF energy activation when used with Olympus consoles.
Anderson Compounding Pharmacy is recalling Prostaglandin Tri-Mix 20:25:1 Injection vials nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Morphine Sulfate 5 mg/3mL inhalation vials due to a lack of sterility assurance. The recall covers 60 vials distributed nationwide.
Anderson Compounding Pharmacy is recalling DMSO 50% and Heparin syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Roche Diagnostics is recalling Tina-quant IgM Gen.2 assays due to new endogenous interference claims that may pose a medical risk on specific analyzers.
Anderson Compounding Pharmacy is recalling Heparin and Lidocaine syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Gyrus ACMI, Inc. is recalling Diego Elite Blades Monopolar because they may allow unintended RF energy activation when used with Olympus consoles.
Anderson Compounding Pharmacy is recalling Estrone 5mg/mL Oil Injection nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Acetylcysteine 10% Ophthalmic Eye Drops due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Prostaglandin Tri-Mix Injection vials because they lack sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Sermorelin 0.4 mg/0.5 mL vials nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling HCG 1,000 U/mL Injection vials nationwide due to a lack of sterility assurance.
Gyrus ACMI is recalling 21 Diego Elite Turbinate Blades because they may allow unintended RF energy activation when used with specific consoles.
MSM Nutraceuticals is recalling 15% MSM Eye Drops because the product is not terminally sterilized and was not tested per USP 71.
Anderson Compounding Pharmacy is recalling Bacitracin 3000U/30 mL Irrigation syringes nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling EDTA 1% Sterile Injection (Preservative Free) nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Interferon 1 Million IU/mL Eye Drops due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Serum Tears 30% Drops due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Prostaglandin Quad with Atropine vials because the product lacks sterility assurance. The recall covers all lots distributed nationwide.